Inactivation of BRCA1 by epigenetic gene silencing in human ovarian tumors.

被引：0
|
作者：
Kawakami, Y. [1 ]
Miyamoto, K. [1 ]
Takehara, K. [1 ]
Nakamura, H. [1 ]
Samura, O. [1 ]
Mizunoe, T. [1 ]
机构：
[1] NHO, Chugoku Canc Ctr, Kure Med Ctr, Hiroshima, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e15524
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15524
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Epigenetic silencing of BRCA1 gene associated with demographic and pathologic factors in sporadic breast cancer: a study of an Indian population
    Singh, Alok Kumar
    Pandey, Anjita
    Tewari, Mallika
    Shukla, Hari Shankar
    Pandey, Hausila Prasad
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2011, 20 (06) : 478 - 483
  • [32] Epigenetic tumor suppression by BRCA1
    Aneliya Velkova
    Alvaro N A Monteiro
    Nature Medicine, 2011, 17 : 1183 - 1185
  • [33] Epigenetic tumor suppression by BRCA1
    Velkova, Aneliya
    Monteiro, Alvaro N. A.
    NATURE MEDICINE, 2011, 17 (10) : 1183 - 1185
  • [34] BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin
    Paul, B. T.
    Blanchard, Z.
    Ridgway, M.
    ElShamy, W. M.
    ONCOGENE, 2015, 34 (23) : 3036 - 3052
  • [35] BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin
    B T Paul
    Z Blanchard
    M Ridgway
    W M ElShamy
    Oncogene, 2015, 34 : 3036 - 3052
  • [36] BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin
    Paul, Bibbin T.
    Blanchard, Zannel
    Ridgway, Mildred
    ElShamy, Wael M.
    CLINICAL CANCER RESEARCH, 2015, 21
  • [37] Status of the BRCA1 gene and incidence of hereditary ovarian cancer
    Synowiec, Agnieszka
    Wcislo, Gabriel
    Bodnar, Lubomir
    Szarlej-Wcislo, Katarzyna
    Cieslak, Agata
    Sieluzycka, Joanna
    Szczylik, Cezary
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2010, 14 (02): : 72 - 78
  • [38] Ovarian cancer gene therapy with a BRCA1 retroviral vector
    Tait, DL
    Obermiller, PS
    Jensen, RA
    Holt, JT
    CANCER GENE THERAPY, 1999, 6 (06) : S1 - S1
  • [39] Genetic Versus Epigenetic BRCA1 Silencing Pathways: Clinical Effects in Primary Ovarian Cancer Patients A Study of the Tumor Bank Ovarian Cancer Consortium
    Sun, Tingting
    Ruscito, Ilary
    Dimitrova, Desislava
    Chekerov, Radoslav
    Kulbe, Hagen
    Baron, Udo
    Blanchard, Ronique
    Panici, Pierluigi Benedetti
    Darb-Esfahani, Silvia
    Sehouli, Jalid
    Olek, Sven
    Braicu, Elena Ioana
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (08) : 1658 - 1665
  • [40] The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancer
    Meisel, J. L.
    Hyman, D. M.
    Garg, K.
    Zhou, Q.
    Dao, F.
    Bisogna, M.
    Gao, J.
    Schultz, N. D.
    Grisham, R. N.
    Phillips, M.
    Iasonos, A.
    Kauff, N. D.
    Levine, D. A.
    Soslow, R. A.
    Spriggs, D. R.
    ANNALS OF ONCOLOGY, 2014, 25 (12) : 2372 - +
12345